In the analyses, 68% percent of patients received prior CHOP-based therapy, 35% had salvage chemotherapy, 20% had autologous stem cell transplant, 17% had an HDAC inhibitor, and 38% had prior exposure ...

Caravel Bio will use the grant money to work on creating new drugs to treat diseases like cancer and help animals as well.

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Alcheme Bio’s initial flagship product, Nutralase, is an enzyme blend that removes bitterness and “beaniness” notes to ...

Quantum physics is usually associated with particle colliders and vacuum chambers, not with the proteins quietly shuttling ...

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ...

Researchers have identified how a single mutation in the GPX4 enzyme causes neurons to undergo ferroptosis, leading to severe early-onset dementia.

The company has also received orphan drug, rare pediatric disease, and fast-track designations for LTS-101 as a potential treatment for the fatal neurodegenerative disease.

Laigo Bio’s SureTAC™ membrane protein degradation technology targets key signaling molecules in autoimmune, graft rejection, and oncology UTRECHT, the Netherlands - 4 December 2025 (08:30 CET). Laigo ...

-- Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors -- Matthew Baker appointed as CEO -- Laigo Bio's SureTAC (TM) membrane protein degradation ...

The global enzyme protectants market is projected to reach USD 1,511.5 million by 2035, rising from USD 820.5 million in 2025 ...

"Everybody is upset about the water quality in the Lake (Okeechobee), but no one really has an answer. This has worked from ...